The Retinoblastoma Gene in Myeloid Leukaemias

References

• Cline, M. J. (1994). The molecular basis of leukemia. N. Engl. J. Med., 330, 328–336.
   PubMed Web of Science ®Google Scholar
• Godbout, R., Dryja, T. P., Squire, J., Gallie, B. L. and Phillips, R. A. (1983). Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature, 304, 451–453.
   PubMed Web of Science ®Google Scholar
• T'Ang, A., Varley, J. M., Chakraborty, S., Murphree, A. L. and Fung, Y. K. (1988). Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science, 242, 263–266.
   PubMed Web of Science ®Google Scholar
• Harbour, J. W., Lai, S. L., Whang Peng, J., Gazdar, A. F., Minna, J. D. and Kaye, F. J. (1988). Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science, 241, 353–357.
   PubMed Web of Science ®Google Scholar
• Ahuja, H. G., Jat, P. S., Foti, A., Bar, E. M. and Cline, M. J. (1991). Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood, 78, 3259–3268.
   PubMed Web of Science ®Google Scholar
• Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y. and Lee, E. Y. (1987). Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science, 235, 1394–1399.
   PubMed Web of Science ®Google Scholar
• Gill, R. M., Hamel, P. A., Zhe, J., Zacksenhaus, E., Gallie, B. L. and Phillips, R. A. (1994). Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Differ., 5, 467–474.
   PubMedGoogle Scholar
• Ohtani-Fujita, N., Fujita, T., Takahashi, R., Robbins, P. D., Dryja, T. P. and Sakai, T. (1994). A silencer element in the retinoblastoma tumor-suppressor gene. Oncogene, 9, 1703–1711.
   PubMed Web of Science ®Google Scholar
• Savoysky, E., Mizuno, T., Sowa, Y., Watanabe, H., Sawada, J. I., Nomura, H., Ohsugi, Y., Handa, H. and Sakai, T. (1994). The retinoblastoma binding factor 1 (RBF-1) site in RB gene promoter binds preferentially E4TF1, a member of the Ets transcription factors family. Oncogene, 9 1839–1846.
   PubMed Web of Science ®Google Scholar
• Sakai, T., Ohtani, N., McGee, T. L., Robbins, P. D. and Dryja, T. P. (1991). Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature, 353, 83–86.
   PubMed Web of Science ®Google Scholar
• Ohtani, F. N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D. and Sakai, T. (1993). CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. Oncogene, 8, 1063–1067.
   PubMed Web of Science ®Google Scholar
• Bookstein, R., Lee, E. Y., To, H., Young, L. J., Sery, T. W., Hayes, R. C., Friedmann, T. and Lee, W. H. (1988). Human retinoblastoma susceptibility gene: genomic organization and analysis of heterozygous intragenic deletion mutants. Proc. Natl. Acad. Sci. USA, 85, 2210–2214.
   PubMed Web of Science ®Google Scholar
• Wiggs, J., Nordenskjold, M., Yandell, D., Rapaport, J., Grondin, V., Janson, M., Werelius, B., Petersen, R., Craft, A., Riedel, K. and et al. (1988). Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N. Engl. J. Med., 318, 151–157.
   PubMed Web of Science ®Google Scholar
• Goodrich, D. W. and Lee, W. H. (1993). Molecular characterization of the retinoblastoma susceptibility gene. Biochiin. Biophys. Acta., 1155, 43–61.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W. and Skuse, G. R. (1995). Viral oncoprotein binding to pRB, p107, p130, and p300. Virus Res., 35, 113–121.
   PubMed Web of Science ®Google Scholar
• Li, Y., Graham, C., Lacy, S., Duncan, A. M. and Whyte, P. (1993). The adenovirus E1A-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev., 7, 2366–2377.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B. (1974). A restriction point for control of normal animal cell proliferation. Proc. Natl. Acad. Sci. USA, 71, 1286–1290.
   PubMed Web of Science ®Google Scholar
• Pardee, A. B., Dubrow, R., Hamlin, J. L. and Kletzien, R. F. (1978). Animal cell cycle. Annu. Rev. Biochem., 47, 715–750.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. (1995). The retinoblastoma protein and cell cycle control. Cell, 81, 323–330.
   PubMed Web of Science ®Google Scholar
• Pines, J. (1995). Cyclins, CDKs and cancer. Semin. Cancer. Biol., 6, 63–72.
   PubMed Web of Science ®Google Scholar
• Charollais, R. H., Tiwari, S. and Thomas, N. S. (1994). Into and out of G1: the control of cell proliferation. Biochimie, 76, 887–894.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., Ludlow, J. W., Lynch, D., Furukawa, Y., Griffin, J., Piwnica Worms, H., Huang, C. M. and Livingston, D. M. (1989). The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell, 58, 1085–1095.
   PubMed Web of Science ®Google Scholar
• Chellappan, S. P., Hiebert, S., Mudryj, M., Horowitz, J. M. and Nevins, J. R. (1991). The E2F transcription factor is a cellular target for the RB protein. Cell, 65, 1053–1061.
   PubMed Web of Science ®Google Scholar
• Kim, S. J., Wagner, S., Liu, F., O'Reilly, M. A., Robbins, P. D. and Green, M. R. (1992). Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature, 358, 331–334.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., Phillips, R. A., Muncaster, M. and Gallie, B. L. (1993). Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J., 7, 846–854.
   PubMed Web of Science ®Google Scholar
• Haas-Kogan, D. A., Kogan, S. C., Levi, D., Dazin, P., Tang, A., Fung, Y. and Israel, M. A. (1995). Inhibition of apoptosis by the retinoblastoma gene product. EMBO Journal, 14, 461–472.
   PubMed Web of Science ®Google Scholar
• Lee, E. Y., Chang, C. Y., Hu, N., Wang, Y. C., Lai, C. C., Herrup, K., Lee, W. H. and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature, 359, 288–294.
   PubMed Web of Science ®Google Scholar
• Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M., van der Valk, M., Hooper, M. L., Berns, A. and te Riele, H. (1992). Requirement for a functional Rb-1 gene in murine development. Nature, 359, 328–330.
   PubMed Web of Science ®Google Scholar
• Coppola, J. A., Lewis, B. A. and Cole, M. D. (1990). Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene 5, 1731–1733.
   PubMed Web of Science ®Google Scholar
• Mistchenko, A. S., Diez, R. A., Romquin, N., Sanceau, J. and Wietzerbin, J. (1993). Interferon-gamma modulates retinoblastoma gene mRNA in monocytoid cells. Int. J. Cancer, 53, 87–90.
   PubMed Web of Science ®Google Scholar
• Yen, A. and Varvayanis, S. (1995). RB phosphorylation in sodium butyrate-resistant HL-60 cells: cross-resistance to retinoic acid but not vitamin D3. J. Cell. Physiol., 163, 502–509.
   PubMed Web of Science ®Google Scholar
• Belka, C., Greger, V., Zabel, B. and Horsthemke, B. (1991). No evidence for sequences structurally related to the RB1 gene in the human genome. Hum. Genet., 86, 401–403.
   PubMed Web of Science ®Google Scholar
• Lohmann, D. R., Brandt, B., Hopping, W., Passarge, E. and Horsthemke, B. (1994). Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma. Hum. Genet., 94, 349–354.
   PubMed Web of Science ®Google Scholar
• Blanquet, V., Turleau, C., Gross Morand, M. S., Senamaud Beaufort, C., Doz, F. and Besmond, C. (1995). Spectrum of germline mutations in the RB1 gene: a study of 232 patients with hereditary and non hereditary retinoblastoma. Hum. Mol. Genet., 4, 383–388.
   PubMed Web of Science ®Google Scholar
• Yee, A. S., Reichel, R., Kovesdi, I. and Nevins, J. R. (1987). Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multicomponent complex. EMBO J., 6, 2061–2068.
   PubMed Web of Science ®Google Scholar
• Paggi, M. G., de Fabritis, P., Bonetto, F., Amadio, L., Santarelli, G., Spadea, A., Gentile, F. P., Floridi, A. and Felsani, A. (1995). The retinoblastoma gene product in acute myeloid leukemia: A possible involvement in promyelocytic leukemia. Cancer Res., 55, 4552–4556.
   PubMed Web of Science ®Google Scholar
• Chen, Y. C., Chen, P. J., Yeh, S. H., Tien, H. F., Wang, C. H., Tang, J. L. and Hong, R. L. (1990). Deletion of the human retinoblastoma gene in primary leukemias. Blood 76, 2060–2064.
   PubMed Web of Science ®Google Scholar
• Jamal, R., Gale, R. E., Thomas, N. S. B. and Linch, D. C. (1996). The retinoblastoma gene in acute myeloid leukaemia: Analysis of gene rearrangements, protein expression and disease outcome. Br. J. Haematol. (In press).
   Google Scholar
• Tang, J. L., Yeh, S. H., Chen, P. J., Lin, M. T., Tien, H. F. and Chen, Y. C. (1992). Inactivation of the retinoblastoma gene in acute myelogenous leukaemia. Br. J. Haematol 82, 502–507.
   PubMed Web of Science ®Google Scholar
• Weide, R., Parviz, B., Pfluger, K. H. and Havemann, K. (1993). Altered expression of the human retinoblastoma gene in monocytic leukaemias. Br. J. Haematol., 83, 428–432.
   PubMed Web of Science ®Google Scholar
• Zhu, Y. M., Bradbury, D. and Russell, N. (1994a). Decreased retinoblastoma protein expression in acute myeloblastic leukaemia is associated with the autonomous proliferation of clonogenic blasts. Br. J. Haematol., 86, 533–539.
   PubMed Web of Science ®Google Scholar
• Kornblau, S. M., Xu, H. J., Zhang, W., Hu, S. X., Beran, M., Smith, T. L., Hester, J., Estey, E., Benedict, W. F. and Deisseroth, A. B. (1994). Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood, 84, 256–261.
   PubMed Web of Science ®Google Scholar
• Jamal, R., Gale, R. E., Thomas, N. S. B. and Linch, D. C. (1994). Analysis of RB1 gene rearrangements in patients with acute myeloid leukaemia. Br. J. Haematol., 86, Suppl 1, 9.
   Google Scholar
• Zhu, Y. M., Bradbury, D. A., Keith, F. J. and Russell, N. (1994b). Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia, 8, 1982–1988.
   PubMed Web of Science ®Google Scholar
• Lugo, T. G., Pendergast, A. M., Muller, A. J. and Witte, O. N. (1990). Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science, 247, 1079–1082.
   PubMed Web of Science ®Google Scholar
• Towatari, M., Adachi, K., Kato, H. and Saito, H. (1991). Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood, 78, 2178–2181.
   PubMed Web of Science ®Google Scholar
• Furukawa, Y., DeCaprio, J. A., Belvin, M. and Griffin, J. D. (1991). Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells. Oncogene, 6, 1343–1346.
   PubMed Web of Science ®Google Scholar
• Gaidano, G., Guerrasio, A., Serra, A., Rege Cambrin, G. and Saglio, G. (1994). Molecular mechanisms of tumor progression in chronic myeloproliferative disorders. Leukemia, 8, Suppl 1, S27–29.
   PubMedGoogle Scholar
• Silly, H., Chase, A., Mills, K. I., Apfelbeck, U., Sormann, S., Goldman, J. M. and Cross, N. C. (1994). No evidence for microsatellite instability or consistent loss of heterozygosity at selected loci in chronic myeloid leukaemia blast crisis. Leukemia, 8, 1923–1928.
   PubMed Web of Science ®Google Scholar
• Blick, M., Romero, P., Talpaz, M., Kurzrock, R., Shtalrid, M., Andersson, B., Trujillo, J., Beran, M. and Gutterman, J. (1987). Molecular characteristics of chronic myelogenous leukemia in blast crisis. Cancer Genet. Cytogenet., 27, 349–56.
   PubMed Web of Science ®Google Scholar
• Dhingra, K., Talpaz, M., Kantarjian, H., Ku, S., Rothberg, J., Gutterman, J. U. and Kurzrock, R. (1991). Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression. Leukemia 5, 191–5.
   PubMed Web of Science ®Google Scholar
• Cline, M. J., Jat, P. S. and Foti, A. (1992). Molecular mechanisms in the evolution of chronic myelocytic leukemia. Leuk. Lymphoma., 7, 283–287.
   PubMed Web of Science ®Google Scholar
• Wetzler, M., Talpaz, M., Estrov, Z. and Kurzrock, R. (1993). CML: mechanisms of disease initiation and progression. Leuk. Lymphoma., 1, 47–50.
   Web of Science ®Google Scholar
• Presti, J. J., Reuter, V. E., Galan, T., Fair, W. R. and Cordon, C. C. (1991). Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res., 51, 5405–5409.
   PubMed Web of Science ®Google Scholar
• Cairns, P., Proctor, A. J. and Knowles, M. A. (1991). Loss of heterozygosity at the RB locus is frequent and correlates with muscle invasion in bladder carcinoma. Oncogene, 6, 2305–2309.
   PubMed Web of Science ®Google Scholar
• Xu, H. J., Cairns, P., Hu, S. X., Knowles, M. A. and Benedict, W. F. (1993). Loss of RB protein expression in primary bladder cancer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer, 53, 781–784.
   PubMed Web of Science ®Google Scholar
• Cance, W. G., Brennan, M. F., Dudas, M. E., Huang, C. M. and Cordon, C. C. (1990). Altered expression of the retinoblastoma gene product in human sarcomas. N. Engl. J. Med., 323, 1457–1462.
   PubMed Web of Science ®Google Scholar
• Pietilainen, T., Lipponen, P., Aaltomaa, S., Eskelinen, M., Kosma, V. M. and Syrjanen, K. (1995). Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur. J. Cancer Part A: General Topics, 31, 329–333.
   Web of Science ®Google Scholar
• Kornblau, S. M., Xu, H. J., del Giglio, A., Hu, S. X., Zhang, W., Calvert, L., Beran, M., Estey, E., Andreeff, M., Trujillo, J. and et al. (1992). Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res., 52, 4587–4590.
   PubMed Web of Science ®Google Scholar
• Kornblau, S. M., Xu, H. J., Hu, S. X., Estey, E., Benedict, W. F. and Deisseroth, A. B. (1995). Low and maximally phosphorylated levels of the retinoblastoma (RB) protein confer poor prognosis at diagnosis in newly diagnosed acute myelogenous leukemia: A prospective study. Blood, 86, Suppl 1, 599a.
   Google Scholar
• Weide, R., Parviz, B., Pfluger, K. H., Koppler, H., Wormann, B., Zuhlsdorf, M. and Havemann, K. (1995). The role of decreased retinoblastoma protein expression in acute myelomonocytic and monoblastic leukemias. Leuk. Lymphoma., 17, 135–137.
   PubMed Web of Science ®Google Scholar
• Wheatley, K., Burnett, A., Goldstone, A., Hann, I., Stevens, R., Rees, J. and Gray, R. (1995). A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom Medical Research Council (MRC) AML10 trial. Blood, 86, Suppl 1, 598a.
   PubMed Web of Science ®Google Scholar
• Hockenberry, D., Nunez, G., Platt, F. M., McKearn, J. P. and Korsmeyer, S. J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programme cell death. Nature, 348, 334–336.
   PubMed Web of Science ®Google Scholar
• El-Deiry, W., Harper, J., O'Connor, P., Velculescu, V., Canman, C., Jackman, J., Pietenpol, J., Burrell, M., Hill, D., Wang, Y., Wiman, K., Mercer, W., Kastan, M., Kohn, K., Elledge, S., Kinzler, K. and Vogelstein, B. (1994). WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54, 1169–1174.
   PubMed Web of Science ®Google Scholar